McCord JMOxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med312: 159-163, 1985.
2.
Zimmerman ANE , Daenes W., Hahman WC, et al. Morphological changes of heart muscle caused by successive perfusion of calcium-free or calcium-containing solutions (calcium paradox). Cardiovasc Res1:201-209, 1967.
Harman JWThe significance of local vascular phenomena in the production of ischemic necrosis in skeletal muscle. Am J Pathol24:625-641, 1949.
5.
Ames A., Wright RL, Kowada M., et al. Cerebral ischemia—The no-reflow phenomenon. Am J Pathol52:437-450, 1968.
6.
Flores J., DiBona DR, Beck CH, et al. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solution. J Clin Invest51:118-127, 1972.
7.
Jameson RLThe role of cellular swelling in the pathogenesis of organ ischemia . West J Med3:205-216, 1974.
8.
Welbourn CRB , Goldman G., Paterson IS, et al. Neutrophil elastase and oxygen radicals: Synergism in lung injury after hind limb ischemia . Am J Physiol260:H1852-H1856, 1991.
9.
Akimitsu T., Gute DC, Jerome SN, et al. Reactive oxygen metabolites and their consequences. In Fantini GA, ed. Ischemia-Reperfusion Injury of Skeletal Muscle. Austin, Tex.: R.G. Landes Co., 1994, pp 5-31.
10.
Pappas PJ, Duran WNPlatelet-activating factor. In Fantini GA , ed. Ischemia-Reperfusion Injury of Skeletal Muscle . Austin, Tex.: R.G. Landes Co ., 1994 , pp 61-76.
11.
Lindsay TF , Rubin BB, Romaschin AD, et al. Complement activation. In Fantini GA, ed. Ischemia-Reperfusion Injury of Skeletal Muscle. Austin, Tex.: R.G. Landes Co., 1994 , pp 77-92.
12.
Baue AEThe horror autotoxicus and multiple-organ failure. Arch Surg127:1451-1462, 1992.
13.
Beversdorf F., Mathais G., Kruger S., et al. Avoiding reperfusion injury after limb revascularization: Experimental observations and recommendations for clinical application. J Vasc Surg9:757-766, 1979.
14.
Perry MOIschemia-reperfusion syndromes: Clinical relevance. J Vasc Surg18:102-104, 1993.
